Pfizer R&D Chief Mikael Dolsten Reflects On The COVID-19 Pandemic Experience

Part 1 Of 2

 
• By Jessica Merrill
  
Mikael Dolsten, M.D., Ph.D., Chief Scientific Officer and President, Worldwide Research, Development and Medical of Pfizer Inc.
Pfizer Worldwide president R&D Mikael Dolsten • Source: Pfizer (WENDY BARROWS photography)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Leadership

More from Scrip